Your browser doesn't support javascript.
loading
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial.
Mennitto, A; Verzoni, E; Cognetti, F; Miceli, R; Milella, M; Mosca, A; Chiuri, V E; Bearz, A; Morelli, F; Ortega, C; Atzori, F; Donini, M; Claps, M; Guadalupi, V; Sepe, P; Cappelletti, V; de Braud, F G; Procopio, G.
Affiliation
  • Mennitto A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Verzoni E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cognetti F; Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy.
  • Miceli R; Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Milella M; Department of Medicine, Medical Oncology, University and Hospital Trust of Verona, Verona, Italy.
  • Mosca A; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Chiuri VE; Medical Oncology Department, Ospedale Vito Fazzi, Lecce, Italy.
  • Bearz A; Medical Oncology Department, National Cancer Institute, Aviano, Italy.
  • Morelli F; Medical Oncology Department, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Ortega C; Department of Medical Oncology, Ospedale S. Lazzaro ASL CN2 Alba-Bra, Cuneo, Italy.
  • Atzori F; Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, Italy.
  • Donini M; Medical Oncology Department, Ospedale di Cremona, Cremona, Italy.
  • Claps M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Guadalupi V; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Sepe P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cappelletti V; Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.
  • de Braud FG; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Procopio G; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy.
Expert Rev Clin Pharmacol ; 14(2): 261-268, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33472450
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Metastasectomy / Sorafenib / Kidney Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Metastasectomy / Sorafenib / Kidney Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2021 Document type: Article Affiliation country: Country of publication: